You are here

Home › UK approves Novavax COVID shot for 12-17 year-olds › UK approves Novavax COVID shot for 12-17 year-olds

UK approves Novavax COVID shot for 12-17 year-olds

Primary tabs

UK approves Novavax COVID shot for 12-17 year-olds

Fri, 2022-08-26 12:37 — mike kraft
Britain approves Novavax COVID shot for 12-17 year-olds Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years. Reuters Reuters

...

The mRNA vaccines made by Moderna as well as the partnership between Pfizer-BioNTech are also cleared for use by this age group, the Medicines and Healthcare products Regulatory Agency (MHRA) said. ...

Country / Region Tags: 
Global
UK - London
United Kingdom
General Topic Tags: 
COVID-19
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
RAC Vaccines and Vaccination Group
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks